Posts

Showing posts with the label Vascular Grafts Market Size

Vascular Grafts Market To Witness A Significant Growth Of USD 2.7 Billion By 2028

Image
  San Francisco, 31 Dec 2021:   The Report  Vascular Grafts Market  Size, Share & Trends Analysis Report By Product, By Application (Cardiac Aneurysm, Kidney Failure, Coronary Artery Disease, By Raw Material (Polyester, Polyurethane), By Region, And Segment Forecasts, 2021 - 2028 The global vascular grafts market size is expected to reach USD 2.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.8% from 2021 to 2028. The increasing prevalence of various cardiovascular disorders, such as Myocardial Infarction (MI), Coronary Heart Disease (CHD) or Coronary Artery Disease (CAD), and stroke, coupled with rising demand for minimally invasive surgeries among the patient population is boosting the market growth. In addition, the market is further driven by a wide number of medical applications and improvements in the development of intraoperative techniques. For instance, the number of peripheral artery procedures incre

Vascular Grafts Market Expanding At A CAGR Of 6.4% For The Forecast Period From 2019 To 2026 : Grand View Research Inc.

San Francisco, 28 May 2019:  The Report  Vascular Grafts Market  Size, Share & Trends Analysis Report By Product (Peripheral, Endovascular Stent), By Application (Vascular Occlusion, Cardiac Aneurysms), By Raw Material (PTFE, Polyester), And Segment Forecasts, 2019 – 2026 The global Vascular Grafts Market size is projected to reach at USD 3.30 billion by 2026 expanding at a CAGR of 6.4%, according to a report by Grand View Research, Inc. Endovascular stent grafts dominated the market in 2018 and is expected to be the second fastest-growing segment over the forecast period. Increasing prevalence of cardiovascular aneurysms is the leading cause of rise in demand for endovascular stent grafts. Low levels of physical activity, sedentary lifestyle, and substance abuse are some of the key factors leading to the high prevalence of renal and Cardiac Diseases (CVDs) globally. The impact of these factors is especially high in developed economies, such as North America and Europe. However,